Notification That Annual Report Will Be Submitted Late (nt 10-k)
April 01 2021 - 6:02AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON
D.C. 20549
|
|
|
|
|
FORM
12b-25
|
|
|
NOTIFICATION
OF LATE FILING
|
|
(Check
One):
|
[X]
Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR
|
For
Period Ended: December 31, 2020
[ ]
Transition Report on Form 10-K
[ ]
Transition Report on Form 20-F
[ ]
Transition Report on Form 11-K
[ ]
Transition Report on Form 10-Q
[ ]
Transition Report on Form N-SAR
For
the Transition Period Ended: ____________________________
Read
Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I - REGISTRANT INFORMATION
|
QSAM
BIOSCIENCES, INC.
|
|
|
Full
Name of Registrant
|
|
|
|
|
|
Former
Name if Applicable
|
|
|
9442
Capital of Texas HWY N
Plaza
1, Suite 500
|
|
|
Address
of Principal Executive Office (Street and Number)
|
|
|
|
|
|
Austin,
TX 78759
|
|
|
City,
State, Zip Code
|
|
PART
II - RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check box if appropriate)
|
|
(a)
|
The
reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
[X]
|
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof,
will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of
transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed
due date; and
|
|
|
(c)
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART
III - NARRATIVE
State
below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion
thereof could not be filed within the prescribed time period. (Attach extra sheets if needed)
The
Form 10-K could not be filed within the prescribed time because additional time is required by the Company’s management
and auditors to prepare certain financial information to be included in such report. The Company is working diligently to complete
the necessary work and review of internal controls. The Company expects to file its 10-K within the extension period provided
under Rule 12b-25.
PART
IV - OTHER INFORMATION
(1)
|
Name
and telephone number of person to contact in regard to this notification:
|
|
Christopher
Nelson
|
|
(512)
|
|
343-4558
|
|
(Name)
|
|
Area
Code
|
|
(Telephone
No.)
|
(2)
|
Have
all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required
to file such report(s) been filed? If the answer is no, identify report(s). [X] Yes [ ] No
|
|
|
(3)
|
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the subject report or portion thereof? [ ] Yes [X] No
|
|
|
|
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
|
|
|
|
QSAM
Biosciences, Inc.
|
|
|
(Name
of Registrant as Specified in Charter)
|
|
has
caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
Date:
|
March
31, 2021
|
By:
|
/s/
Christopher Nelson
|
|
|
Name:
|
Christopher
Nelson
|
|
|
Title:
|
General
Nelson
|